Biomarkers for sporadic Creutzfeldt-Jakob disease

Sanam Soomro, Chandra Mohan

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Sporadic Creutzfeldt-Jakob disease (sCJD) is a rare but fatal type of spongiform encephalopathy with unknown cause. Unfortunately, definitive diagnosis of this disease can only be done by examination of postmortem brain tissue. Presumptive diagnosis is done through a combination of clinical manifestations, radiology results, and cerebrospinal fluid (CSF) testing for CSF 14-3-3. Even with these guidelines, premortem diagnosis of sCJD can be unreliable with high rates of misdiagnosis. This calls for more reliable biomarkers of the disease, allowing for better diagnosis as well as understanding the pathogenesis of sCJD. This review compiles potential genetic, protein, biomolecular, and imaging biomarker studies for sCJD since 2010, highlighting the promise of proteins, cytokines, and composite biomarkers for improving the diagnosis as well as understanding the pathogenesis of this mysterious ailment.

Original languageEnglish (US)
Pages (from-to)465-472
Number of pages8
JournalAnnals of Clinical and Translational Neurology
Volume3
Issue number6
DOIs
StatePublished - Jun 1 2016

Fingerprint

Biomarkers
Cerebrospinal Fluid
Brain Diseases
Diagnostic Errors
Radiology
Autopsy
Proteins
Sporadic Creutzfeldt-Jakob Disease
Guidelines
Cytokines
Brain

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Biomarkers for sporadic Creutzfeldt-Jakob disease. / Soomro, Sanam; Mohan, Chandra.

In: Annals of Clinical and Translational Neurology, Vol. 3, No. 6, 01.06.2016, p. 465-472.

Research output: Contribution to journalReview article

Soomro, Sanam ; Mohan, Chandra. / Biomarkers for sporadic Creutzfeldt-Jakob disease. In: Annals of Clinical and Translational Neurology. 2016 ; Vol. 3, No. 6. pp. 465-472.
@article{40db81919cce4c2d8cd683cac67d57c9,
title = "Biomarkers for sporadic Creutzfeldt-Jakob disease",
abstract = "Sporadic Creutzfeldt-Jakob disease (sCJD) is a rare but fatal type of spongiform encephalopathy with unknown cause. Unfortunately, definitive diagnosis of this disease can only be done by examination of postmortem brain tissue. Presumptive diagnosis is done through a combination of clinical manifestations, radiology results, and cerebrospinal fluid (CSF) testing for CSF 14-3-3. Even with these guidelines, premortem diagnosis of sCJD can be unreliable with high rates of misdiagnosis. This calls for more reliable biomarkers of the disease, allowing for better diagnosis as well as understanding the pathogenesis of sCJD. This review compiles potential genetic, protein, biomolecular, and imaging biomarker studies for sCJD since 2010, highlighting the promise of proteins, cytokines, and composite biomarkers for improving the diagnosis as well as understanding the pathogenesis of this mysterious ailment.",
author = "Sanam Soomro and Chandra Mohan",
year = "2016",
month = "6",
day = "1",
doi = "10.1002/acn3.304",
language = "English (US)",
volume = "3",
pages = "465--472",
journal = "Annals of Clinical and Translational Neurology",
issn = "2328-9503",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - Biomarkers for sporadic Creutzfeldt-Jakob disease

AU - Soomro, Sanam

AU - Mohan, Chandra

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Sporadic Creutzfeldt-Jakob disease (sCJD) is a rare but fatal type of spongiform encephalopathy with unknown cause. Unfortunately, definitive diagnosis of this disease can only be done by examination of postmortem brain tissue. Presumptive diagnosis is done through a combination of clinical manifestations, radiology results, and cerebrospinal fluid (CSF) testing for CSF 14-3-3. Even with these guidelines, premortem diagnosis of sCJD can be unreliable with high rates of misdiagnosis. This calls for more reliable biomarkers of the disease, allowing for better diagnosis as well as understanding the pathogenesis of sCJD. This review compiles potential genetic, protein, biomolecular, and imaging biomarker studies for sCJD since 2010, highlighting the promise of proteins, cytokines, and composite biomarkers for improving the diagnosis as well as understanding the pathogenesis of this mysterious ailment.

AB - Sporadic Creutzfeldt-Jakob disease (sCJD) is a rare but fatal type of spongiform encephalopathy with unknown cause. Unfortunately, definitive diagnosis of this disease can only be done by examination of postmortem brain tissue. Presumptive diagnosis is done through a combination of clinical manifestations, radiology results, and cerebrospinal fluid (CSF) testing for CSF 14-3-3. Even with these guidelines, premortem diagnosis of sCJD can be unreliable with high rates of misdiagnosis. This calls for more reliable biomarkers of the disease, allowing for better diagnosis as well as understanding the pathogenesis of sCJD. This review compiles potential genetic, protein, biomolecular, and imaging biomarker studies for sCJD since 2010, highlighting the promise of proteins, cytokines, and composite biomarkers for improving the diagnosis as well as understanding the pathogenesis of this mysterious ailment.

UR - http://www.scopus.com/inward/record.url?scp=85026248361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026248361&partnerID=8YFLogxK

U2 - 10.1002/acn3.304

DO - 10.1002/acn3.304

M3 - Review article

C2 - 27547775

AN - SCOPUS:85026248361

VL - 3

SP - 465

EP - 472

JO - Annals of Clinical and Translational Neurology

JF - Annals of Clinical and Translational Neurology

SN - 2328-9503

IS - 6

ER -